XOMA (XOMA) News Today $30.21 +0.33 (+1.10%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period XOMA Co. (NASDAQ:XOMA) Sees Significant Decrease in Short InterestXOMA Co. (NASDAQ:XOMA - Get Free Report) was the recipient of a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 173,300 shares, a drop of 23.5% from the October 15th total of 226,400 shares. Based on an average trading volume of 22,100 shares, the days-to-cover ratio is presently 7.8 days.November 15 at 4:42 AM | marketbeat.comOwen Hughes Sells 21,881 Shares of XOMA Co. (NASDAQ:XOMA) StockNovember 14 at 8:16 AM | insidertrades.comHC Wainwright Has Optimistic Outlook of XOMA FY2025 EarningsNovember 11, 2024 | americanbankingnews.comWhat is HC Wainwright's Estimate for XOMA FY2025 Earnings?XOMA Co. (NASDAQ:XOMA - Free Report) - Investment analysts at HC Wainwright raised their FY2025 earnings estimates for XOMA in a note issued to investors on Thursday, November 7th. HC Wainwright analyst J. Pantginis now forecasts that the biotechnology company will post earnings of $0.17 per sharNovember 11, 2024 | marketbeat.comXOMA Royalty Corporation (NASDAQ:XOMA) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their EstimatesNovember 10, 2024 | finance.yahoo.comXOMA Royalty Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsNovember 9, 2024 | finance.yahoo.comXOMA Royalty’s Third Quarter 2024 Financial InsightsNovember 8, 2024 | markets.businessinsider.comStrategic Positioning and Growth Potential Drive Buy Rating for XomaNovember 8, 2024 | markets.businessinsider.comXOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent ActivitiesNovember 7, 2024 | globenewswire.comXOMA (NASDAQ:XOMA) Stock Price Crosses Above Two Hundred Day Moving Average - Here's WhyXOMA (NASDAQ:XOMA) Stock Crosses Above Two Hundred Day Moving Average - Here's WhyNovember 5, 2024 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for XOMA (NASDAQ:XOMA)HC Wainwright restated a "buy" rating and issued a $117.00 price target on shares of XOMA in a research report on Wednesday.October 23, 2024 | marketbeat.comXoma enters $15M royalty monetization arrangement with Twist BioscienceOctober 22, 2024 | markets.businessinsider.comXoma’s Strategic Partnerships and Pipeline Growth Position It as a Strong Investment OpportunityOctober 22, 2024 | markets.businessinsider.comXOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist BioscienceOctober 22, 2024 | globenewswire.comEllsworth Advisors LLC Makes New $516,000 Investment in XOMA Co. (NASDAQ:XOMA)Ellsworth Advisors LLC acquired a new stake in shares of XOMA Co. (NASDAQ:XOMA - Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 19,475 shares of the biotechnology company's stock, valuedOctober 19, 2024 | marketbeat.comXOMA Stock Dips Amidst Biotech Sector DeclineOctober 3, 2024 | gurufocus.comXOMA (NASDAQ:XOMA) Shares Pass Above 200-Day Moving Average of $25.91XOMA (NASDAQ:XOMA) Shares Pass Above 200-Day Moving Average of $25.91September 28, 2024 | marketbeat.comXOMA Poised for Growth: FDA Approval of Miplyffa and Strategic Acquisitions Underpin Buy RatingSeptember 25, 2024 | markets.businessinsider.comZevra's MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)September 23, 2024 | globenewswire.comXOMA Royalty Declares Quarterly Preferred Stock DividendsSeptember 23, 2024 | globenewswire.comXOMA (NASDAQ:XOMA) Stock Passes Above 200 Day Moving Average of $25.74XOMA (NASDAQ:XOMA) Stock Price Passes Above 200-Day Moving Average of $25.74September 17, 2024 | marketbeat.comXOMA Royalty Corp. 8.625% Pfd. Series ASeptember 5, 2024 | wsj.comXOMA Royalty to Present at Upcoming Investor Conferences in SeptemberSeptember 4, 2024 | globenewswire.comXOMA (NASDAQ:XOMA) Stock Price Crosses Above Two Hundred Day Moving Average of $25.53XOMA (NASDAQ:XOMA) Share Price Crosses Above 200-Day Moving Average of $25.53September 4, 2024 | marketbeat.comXOMA (NASDAQ:XOMA) Stock Price Crosses Above Two Hundred Day Moving Average of $25.18XOMA (NASDAQ:XOMA) Stock Crosses Above 200-Day Moving Average of $25.18August 27, 2024 | marketbeat.comRisinger Affirms Buy Rating on Xoma with Increased Price Target Amid Strong Financial Performance and Unrecognized Asset PotentialAugust 16, 2024 | markets.businessinsider.comHC Wainwright Raises XOMA (NASDAQ:XOMA) Price Target to $117.00HC Wainwright boosted their target price on shares of XOMA from $74.00 to $117.00 and gave the stock a "buy" rating in a report on Thursday.August 15, 2024 | marketbeat.comXOMA (NASDAQ:XOMA) Upgraded to Hold at StockNews.comStockNews.com raised XOMA from a "sell" rating to a "hold" rating in a research note on Wednesday.August 14, 2024 | marketbeat.comXOMA Stock Earnings: XOMA Misses EPS, Beats Revenue for Q2 2024August 13, 2024 | investorplace.comXOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent ActivitiesAugust 13, 2024 | globenewswire.comBMRN Aug 2024 115.000 call (BMRN240816C00115000)August 3, 2024 | finance.yahoo.comU.S. Biodefense Industry Research 2024-2030: Focus on Anthrax, Small Pox, Botulism, & Radiation/NuclearJuly 25, 2024 | finance.yahoo.comLatigo Biotherapeutics Appoints Nima Farzan as Chief Executive Officer, Positioning Company for Rapid GrowthJuly 22, 2024 | finance.yahoo.comXOMA (NASDAQ:XOMA) Stock Price Passes Above 200-Day Moving Average of $23.83XOMA (NASDAQ:XOMA) Share Price Crosses Above 200 Day Moving Average of $23.83July 17, 2024 | marketbeat.comXOMA's (XOMA) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $74.00 target price on shares of XOMA in a research report on Tuesday.July 9, 2024 | marketbeat.comXOMA Corporation: A Hold Rating With Steady Income From Preferred SharesJune 29, 2024 | seekingalpha.comXOMA (NASDAQ:XOMA) Shares Pass Above Two Hundred Day Moving Average of $22.95XOMA (NASDAQ:XOMA) Shares Pass Above Two Hundred Day Moving Average of $22.95June 25, 2024 | marketbeat.comXOMA Declares Quarterly Preferred Stock DividendsJune 20, 2024 | globenewswire.comXOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals' Sale of its Priority Review VoucherJune 12, 2024 | globenewswire.com3 Crazy Good Stocks to Buy With $500 Right NowJune 12, 2024 | investorplace.comXOMA (NASDAQ:XOMA) Shares Pass Above 200-Day Moving Average of $22.10XOMA (NASDAQ:XOMA) Share Price Passes Above Two Hundred Day Moving Average of $22.10June 8, 2024 | marketbeat.comLadRx and ImmunityBio Mutually Agree to Terminate Aldoxorubicin LicenseJune 3, 2024 | businesswire.comXOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQMay 14, 2024 | globenewswire.comXOMA Stock Earnings: XOMA Misses EPS, Beats Revenue for Q1 2024May 9, 2024 | investorplace.comXOMA Reports First Quarter 2024 Financial Results and Highlights Recent ActivitiesMay 9, 2024 | globenewswire.comQ1 2024 Earnings Forecast for XOMA Co. Issued By Leerink Partnrs (NASDAQ:XOMA)XOMA Co. (NASDAQ:XOMA - Free Report) - Research analysts at Leerink Partnrs issued their Q1 2024 earnings per share (EPS) estimates for XOMA in a report issued on Monday, April 29th. Leerink Partnrs analyst D. Risinger anticipates that the biotechnology company will post earnings of ($0.85) per sMay 2, 2024 | marketbeat.comXOMA (NASDAQ:XOMA) Rating Reiterated by Leerink PartnrsLeerink Partnrs reiterated an "outperform" rating on shares of XOMA in a research note on Monday.May 2, 2024 | marketbeat.comCracking The Code: Understanding Analyst Reviews For XOMAApril 29, 2024 | markets.businessinsider.comXOMA (NASDAQ:XOMA) Receives New Coverage from Analysts at SVB LeerinkSVB Leerink started coverage on XOMA in a research report on Monday. They set an "outperform" rating and a $40.00 price objective on the stock.April 29, 2024 | marketbeat.comXOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)April 25, 2024 | finance.yahoo.com Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Email Address There is a little known company that is changing warfare (Ad)With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military. Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t XOMA Media Mentions By Week XOMA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XOMA News Sentiment▼0.860.55▲Average Medical News Sentiment XOMA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XOMA Articles This Week▼111▲XOMA Articles Average Week Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cue Biopharma News Syros Pharmaceuticals News TherapeuticsMD News Innoviva News OPKO Health News Ironwood Pharmaceuticals News Emergent BioSolutions News Sangamo Therapeutics News Codexis News Lexicon Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XOMA) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share XOMA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XOMA Stock Alerts